An investigation into Zimmer Biomet's Warsaw, Ind.-based manufacturing facility began following a Securities Class Action complaint filed in 2017.
The complaint was filled by shareholders who purchased securities between June 7, 2016 and Nov. 7, 2016. According to the suit, Zimmer Biomet misled the general and investing public regarding quality control issues.
An internal audit found Zimmer Biomet's headquarters in Warsaw misled the public about its products and production.
Zimmer Biomet filed a motion to dismiss the complaint. However, a judge denied the device company's request Sept. 26.